Machine learning identifies candidates for drug repurposing in Alzheimer’s disease

Clinical trials of novel therapeutics for Alzheimer’s Disease (AD) have consumed a large amount of time and resources with largely negative results. Repurposing drugs already approved by the Food and Drug Administration (FDA) for another indication is a more rapid and less expensive option. We prese...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Commun
Main Authors: Rodriguez, Steve, Hug, Clemens, Todorov, Petar, Moret, Nienke, Boswell, Sarah A., Evans, Kyle, Zhou, George, Johnson, Nathan T., Hyman, Bradley T., Sorger, Peter K., Albers, Mark W., Sokolov, Artem
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7884393/
https://ncbi.nlm.nih.gov/pubmed/33589615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-021-21330-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados